Assessment of Immune Response Following Dendritic Cell-Based Immunotherapy in Pediatric Patients With Relapsing Sarcoma

Monocyte-derived dendritic cell (DC)-based vaccines loaded with tumor self-antigens represent a novel approach in anticancer therapy. We evaluated DC-based anticancer immunotherapy (ITx) in an academic Phase I/II clinical trial for children, adolescent, and young adults with progressive, recurrent,...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Front Oncol
Autori principali: Fedorova, Lenka, Mudry, Peter, Pilatova, Katerina, Selingerova, Iveta, Merhautova, Jana, Rehak, Zdenek, Valik, Dalibor, Hlavackova, Eva, Cerna, Dasa, Faberova, Lucie, Mazanek, Pavel, Pavelka, Zdenek, Demlova, Regina, Sterba, Jaroslav, Zdrazilova-Dubska, Lenka
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2019
Soggetti:
Oncology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6868036/
https://ncbi.nlm.nih.gov/pubmed/31799177
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.01169
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi